News

Novo Nordisk slashes 9,000 jobs to slim down in fierce weight-loss drug battle

Novo Nordisk , the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to ...

Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk’s breakup with Hims

GoodRx will offer the GLP-1s for $499 a month, the lowest-ever out-of-pocket cost for the weight-loss medications.

1 Reason Every Investor Should Know About Novo Nordisk (NVO)

It's no secret that Novo Nordisk ( NVO -1.69%) and Eli Lilly ( LLY 1.57%) are toughing it out in the battle of the weight ...

Strong Danish economy can ride out Novo Nordisk downturn, finance minister says

Denmark's economy remains robust despite job cuts at Novo Nordisk , the finance minister told Reuters on Wednesday, ...
Becker's Hospital Review6d

Wegovy gains new approval: 3 GLP-1 updates

Novo Nordisk’s popular weight loss drug, Wegovy, is the first and only GLP-1 medication approved to treat metabolic associated steatohepatitis, a serious condition marked by liver scarring. The FDA ...

Novo Nordisk: A Pharma Leader With Growth Potential And Portfolio-Defensive Appeal

Discover why Novo Nordisk is a top buy with strong GLP-1 drug growth, robust fundamentals, and defensive value.

CVS Caremark faces class-action lawsuit over Zepbound, Wegovy coverage

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...